Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17.

Saved in:
Bibliographic Details
Title: Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17.
Authors: Vickers, M. M.1, Karapetis, C. S.2, Tu, D.3, O'Callaghan, C. J.3, Price, T. J.4, Tebbutt, N. C.5, Van Hazel, G.6, Shapiro, J. D.7, Pavlakis, N.8, Gibbs, P.9, Blondal, J.10, Lee, U.11, Meharchand, J. M.12, Burkes, R. L.13, Rubin, S. H.14, Simes, J.15, Zalcberg, J. R.16, Moore, M. J.17, Zhu, L.3, Jonker, D. J.18
Source: Annals of Oncology. Apr2013, Vol. 24 Issue 4, p953-960. 8p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mds577